We are live on ! Find out more
BNP Paribas Asset Management

BNP Paribas Asset Management Portfolio holdings

AUM $86.1B
1-Year Est. Return 29.11%
This Fund
S&P 500
This Quarter Est. Return
+10.7%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$38.6B
AUM Growth
-$2.38B
Cap. Flow
-$5.21B
Cap. Flow %
-13.5%
Top 10 Hldgs %
28.46%
Holding
2,134
New
53
Increased
880
Reduced
609
Closed
275

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$254M
2
NOW icon
ServiceNow
NOW
+$191M
3
LLY icon
Eli Lilly
LLY
+$123M
4
ISRG icon
Intuitive Surgical
ISRG
+$111M
5
AZO icon
AutoZone
AZO
+$94.8M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.49B
2
NFLX icon
Netflix
NFLX
+$519M
3
WMT icon
Walmart Inc
WMT
+$228M
4
NVDA icon
NVIDIA
NVDA
+$227M
5
CRM icon
Salesforce
CRM
+$208M

Sector Composition

Rank Sector Weight
1 Technology 36.1%
2 Healthcare 13.04%
3 Financials 11.65%
4 Consumer Discretionary 11.6%
5 Communication Services 8.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGNT
1601
AGNT Inc
AGNT
$710M
$9K ﹤0.01%
840
+199
+31% +$2.1K
EZPW icon
1602
Ezcorp Inc
EZPW
$1.65B
$9K ﹤0.01%
474
GERN icon
1603
Geron
GERN
$1B
$9K ﹤0.01%
6,380
HCSG icon
1604
Healthcare Services Group
HCSG
$1.48B
$9K ﹤0.01%
561
HTZ icon
1605
Hertz
HTZ
$895M
$9K ﹤0.01%
1,336
+104
+8% +$668
JANX icon
1606
Janux Therapeutics
JANX
$1B
$9K ﹤0.01%
371
MMI icon
1607
Marcus & Millichap
MMI
$1.16B
$9K ﹤0.01%
314
DFTX
1608
Definium Therapeutics
DFTX
$5.58B
$9K ﹤0.01%
792
+114
+17% +$1.06K
MYGN icon
1609
Myriad Genetics
MYGN
$305M
$9K ﹤0.01%
1,211
PRAX icon
1610
Praxis Precision Medicines
PRAX
$10.2B
$9K ﹤0.01%
163
+30
+23% +$1.46K
PRCH icon
1611
Porch Group
PRCH
$1.78B
$9K ﹤0.01%
+520
New +$7.98K
RUSHB icon
1612
Rush Enterprises Class B
RUSHB
$9.14B
$9K ﹤0.01%
152
-24
-14% -$1.35K
RYZ
1613
Ryerson Holding Corp
RYZ
$1.45B
$9K ﹤0.01%
396
+46
+13% +$1.03K
SAH icon
1614
Sonic Automotive
SAH
$2.54B
$9K ﹤0.01%
116
+39
+51% +$3.11K
SLVM icon
1615
Sylvamo
SLVM
$1.62B
$9K ﹤0.01%
214
-53
-20% -$2.46K
TNDM icon
1616
Tandem Diabetes Care
TNDM
$1.61B
$9K ﹤0.01%
708
+50
+8% +$677
USLM icon
1617
United States Lime & Minerals
USLM
$3.46B
$9K ﹤0.01%
71
ANAB icon
1618
AnaptysBio
ANAB
$1.71B
$8K ﹤0.01%
272
+38
+16% +$872
APGE icon
1619
Apogee Therapeutics
APGE
$10.2B
$8K ﹤0.01%
202
AVXL icon
1620
Anavex Life Sciences
AVXL
$315M
$8K ﹤0.01%
909
AXGN icon
1621
Axogen
AXGN
$2.59B
$8K ﹤0.01%
449
BFC icon
1622
Bank First Corp
BFC
$1.71B
$8K ﹤0.01%
65
+12
+23% +$1.49K
BLND icon
1623
Blend Labs
BLND
$345M
$8K ﹤0.01%
2,090
BY icon
1624
Byline Bancorp
BY
$1.75B
$8K ﹤0.01%
300
CARS icon
1625
Cars.com
CARS
$635M
$8K ﹤0.01%
692

Similar funds

BNP Paribas Asset Management's Q3 2025 Portfolio in Review

As of Q3 2025, BNP Paribas Asset Management held 2,134 positions worth $38.6B, down 5.8% from $41B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

BNP Paribas Asset Management withdrew a net $5.21B in Q3 2025, closing 275 positions and reducing 609 holdings. Its most notable exit was Microsoft, an estimated $2.49B position sold in full.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.

Against the trend, BNP Paribas Asset Management opened a new position in Legence Corp worth $32.5M.

  • BNP Paribas Asset Management's largest Q3 2025 buy was Legence Corp: 1,054,607 shares worth $32.5M.
  • BNP Paribas Asset Management added most to Broadcom in Q3 2025, an estimated $254M increase.
  • BNP Paribas Asset Management's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $227M.
  • BNP Paribas Asset Management fully exited Microsoft in Q3 2025, selling an estimated $2.49B.
  • BNP Paribas Asset Management's ten largest holdings make up 28% of its $38.6B portfolio in Q3 2025.
  • BNP Paribas Asset Management opened 53 new positions and closed 275 in Q3 2025.
  • BNP Paribas Asset Management's portfolio value fell 5.8% quarter-over-quarter to $38.6B.

Based on BNP Paribas Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.